Business
Medical Marijuana, Inc. CEO Featured in Reuters Coverage Highlighting the Impact of COVID-19 on Cannabis Industry
Medical Marijuana, Inc. CEO Featured in Reuters Coverage Highlighting the Impact of COVID-19 on Cannabis Industry.
About this update from Medical Marijuana, Inc.
[{"type":"text","content":"\n\n\n\nMedical Marijuana, Inc. CEO Featured in Reuters Coverage Highlighting the Impact of COVID-19 on Cannabis Industry\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nMedical Marijuana, Inc. CEO Featured in Reuters Coverage Highlighting the Impact of COVID-19 on Cannabis Industry\nPR Newswire\nSAN DIEGO, March 26, 2020\n\n\n\nSAN DIEGO, March 26, 2020 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA) (the \"Company\"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Company's CEO Dr. Stuart Titus was featured in global financial news outlet Reuters discussing the impact of COVID-19 on the cannabis industry.\nThe March 25, 2020, Reuters article entitled \"As customers hoard pot brownies, North American weed firms see lockdown boost,\" provided coverage of a recent surge in cannabis sales during the COVID-19 pandemic and quoted Titus as saying: \"We have seen stockpiling in Canada by consumers who have snapped up products from LPs (licensed producers).\"\nAccording to the article, cannabis retailers in both the U.S. and Canada are seeing a sharp increase in sales, including a 50 percent spike across \"key U.S. markets\" from March 16 to March 22 alone.\n\"Cannabis sales have increased substantially in Canada in recent weeks with some cannabis retailers even reporting growth of 80 to 100 percent,\" Titus said.\nThe article was picked up by several leading global news outlets, including:\nThe New York Times Business Insider Yahoo Finance, and The New York PostAbout Medical Marijuana, Inc.We are a company of firsts®. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds®; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-...